Koppert, L. B.; Wijnhoven, B. P.; Van Dekken, H.; Tilanus, H. W.; Dinjens, W. N. (2005). „The molecular biology of esophageal adenocarcinoma”. J Surg Oncol. 92 (3): 169—90. PMID16299787. S2CID42893278. doi:10.1002/jso.20359.
Cameron, A. J. (2001). „The history of Barrett esophagus”. Mayo Clin Proc. 76 (1): 94—6. PMID11155423. doi:10.4065/76.1.94.
Cameron, A. J. (2001). „The history of Barrett esophagus”. Mayo Clin Proc. 76 (1): 94—6. PMID11155423. doi:10.4065/76.1.94.
Bani-Hani KE, Bani-Hani BK (мај 2008). „Columnar-lined esophagus: time to drop the eponym of "Barrett": Historical review”. Journal of Gastroenterology and Hepatology. 23 (5): 707—15. PMID18410605. S2CID21531132. doi:10.1111/j.1440-1746.2008.05386.x.CS1 одржавање: Формат датума (веза).
Zagari, R. M.; Fuccio, L.; Wallander, M-A; Johansson, S.; Fiocca, R.; Casanova, S.; Farahmand, B. Y.; Winchester, C. C.; Roda, E.; Bazzoli, F. (2008). „Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: The Loiano-Monghidoro study”. Gut. 57 (10): 1354—1359. PMID18424568. S2CID206947077. doi:10.1136/gut.2007.145177.
Zajac, Peter; Holbrook, Abigail; Super, Maria E.; Vogt, Manuel (2013). „An overview: Current clinical guidelines for the evaluation, diagnosis, treatment, and management of dyspepsia”. Osteopathic Family Physician. 5 (2): 79—85. doi:10.1016/j.osfp.2012.10.005.
Paull, A.; Trier, J. S.; Dalton, M. D.; Camp, R. C.; Loeb, P.; Goyal, R. K. (1976-08-26). „The histologic spectrum of Barrett's esophagus”. New England Journal of Medicine. 295 (9): 476—80. PMID940579. doi:10.1056/NEJM197608262950904.
Thrift, A. P. (јул 2016). „Determination of risk for Barrett's esophagus and esophageal adenocarcinoma”. Curr Opin Gastroenterol. 32 (4): 319—24. PMID27276368. S2CID34945427. doi:10.1097/MOG.0000000000000274.CS1 одржавање: Формат датума (веза)
Phillips, W. A.; Lord, R. V.; Nancarrow, D. J.; Watson, D. I.; Whiteman, D. C. (2011). „Barrett's esophagus”. Journal of Gastroenterology and Hepatology. 26 (4): 639—648. PMID21166712. S2CID6540402. doi:10.1111/j.1440-1746.2010.06602.x.
Holmes, Rebecca S.; Vaughan, Thomas L. (2007). „Epidemiology and Pathogenesis of Esophageal Cancer”. Seminars in Radiation Oncology. 17 (1): 2—9. PMID17185192. doi:10.1016/j.semradonc.2006.09.003.
Thomas, T.; Abrams, K. R.; De Caestecker, J. S.; Robinson, R. J. (2007). „Meta analysis: Cancer risk in Barrett's oesophagus”. Alimentary Pharmacology & Therapeutics. 26 (11–12): 1465—1477. PMID17900269. S2CID9930761. doi:10.1111/j.1365-2036.2007.03528.x.
Yousef, Fouad; Cardwell, Chris; Cantwell, Marie M.; Galway, Karen; Johnston, Brian T.; Murray, Liam (2008). „The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis”. American Journal of Epidemiology. 168 (3): 237—249. PMID18550563. doi:10.1093/aje/kwn121.
Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjørn Mohr; Sørensen, Henrik Toft; Funch-Jensen, Peter (2011). „Incidence of Adenocarcinoma among Patients with Barrett's Esophagus”. New England Journal of Medicine. 365 (15): 1375—1383. PMID21995385. doi:10.1056/NEJMoa1103042.
Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjørn Mohr; Sørensen, Henrik Toft; Funch-Jensen, Peter (2011). „Incidence of Adenocarcinoma among Patients with Barrett's Esophagus”. New England Journal of Medicine. 365 (15): 1375—1383. PMID21995385. doi:10.1056/NEJMoa1103042.
Polednak, Anthony P. (2003). „Trends in survival for both histologic types of esophageal cancer in U.S. Surveillance, epidemiology and end results areas”. International Journal of Cancer. 105 (1): 98—100. PMID12672037. S2CID6539230. doi:10.1002/ijc.11029.
Koppert, L. B.; Wijnhoven, B. P.; Van Dekken, H.; Tilanus, H. W.; Dinjens, W. N. (2005). „The molecular biology of esophageal adenocarcinoma”. J Surg Oncol. 92 (3): 169—90. PMID16299787. S2CID42893278. doi:10.1002/jso.20359.
Cameron, A. J. (2001). „The history of Barrett esophagus”. Mayo Clin Proc. 76 (1): 94—6. PMID11155423. doi:10.4065/76.1.94.
Cameron, A. J. (2001). „The history of Barrett esophagus”. Mayo Clin Proc. 76 (1): 94—6. PMID11155423. doi:10.4065/76.1.94.
Bani-Hani KE, Bani-Hani BK (мај 2008). „Columnar-lined esophagus: time to drop the eponym of "Barrett": Historical review”. Journal of Gastroenterology and Hepatology. 23 (5): 707—15. PMID18410605. S2CID21531132. doi:10.1111/j.1440-1746.2008.05386.x.CS1 одржавање: Формат датума (веза).
Zagari, R. M.; Fuccio, L.; Wallander, M-A; Johansson, S.; Fiocca, R.; Casanova, S.; Farahmand, B. Y.; Winchester, C. C.; Roda, E.; Bazzoli, F. (2008). „Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: The Loiano-Monghidoro study”. Gut. 57 (10): 1354—1359. PMID18424568. S2CID206947077. doi:10.1136/gut.2007.145177.
Paull, A.; Trier, J. S.; Dalton, M. D.; Camp, R. C.; Loeb, P.; Goyal, R. K. (1976-08-26). „The histologic spectrum of Barrett's esophagus”. New England Journal of Medicine. 295 (9): 476—80. PMID940579. doi:10.1056/NEJM197608262950904.
Thrift, A. P. (јул 2016). „Determination of risk for Barrett's esophagus and esophageal adenocarcinoma”. Curr Opin Gastroenterol. 32 (4): 319—24. PMID27276368. S2CID34945427. doi:10.1097/MOG.0000000000000274.CS1 одржавање: Формат датума (веза)
Phillips, W. A.; Lord, R. V.; Nancarrow, D. J.; Watson, D. I.; Whiteman, D. C. (2011). „Barrett's esophagus”. Journal of Gastroenterology and Hepatology. 26 (4): 639—648. PMID21166712. S2CID6540402. doi:10.1111/j.1440-1746.2010.06602.x.
Holmes, Rebecca S.; Vaughan, Thomas L. (2007). „Epidemiology and Pathogenesis of Esophageal Cancer”. Seminars in Radiation Oncology. 17 (1): 2—9. PMID17185192. doi:10.1016/j.semradonc.2006.09.003.
Thomas, T.; Abrams, K. R.; De Caestecker, J. S.; Robinson, R. J. (2007). „Meta analysis: Cancer risk in Barrett's oesophagus”. Alimentary Pharmacology & Therapeutics. 26 (11–12): 1465—1477. PMID17900269. S2CID9930761. doi:10.1111/j.1365-2036.2007.03528.x.
Yousef, Fouad; Cardwell, Chris; Cantwell, Marie M.; Galway, Karen; Johnston, Brian T.; Murray, Liam (2008). „The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis”. American Journal of Epidemiology. 168 (3): 237—249. PMID18550563. doi:10.1093/aje/kwn121.
Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjørn Mohr; Sørensen, Henrik Toft; Funch-Jensen, Peter (2011). „Incidence of Adenocarcinoma among Patients with Barrett's Esophagus”. New England Journal of Medicine. 365 (15): 1375—1383. PMID21995385. doi:10.1056/NEJMoa1103042.
Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjørn Mohr; Sørensen, Henrik Toft; Funch-Jensen, Peter (2011). „Incidence of Adenocarcinoma among Patients with Barrett's Esophagus”. New England Journal of Medicine. 365 (15): 1375—1383. PMID21995385. doi:10.1056/NEJMoa1103042.
Polednak, Anthony P. (2003). „Trends in survival for both histologic types of esophageal cancer in U.S. Surveillance, epidemiology and end results areas”. International Journal of Cancer. 105 (1): 98—100. PMID12672037. S2CID6539230. doi:10.1002/ijc.11029.
Koppert, L. B.; Wijnhoven, B. P.; Van Dekken, H.; Tilanus, H. W.; Dinjens, W. N. (2005). „The molecular biology of esophageal adenocarcinoma”. J Surg Oncol. 92 (3): 169—90. PMID16299787. S2CID42893278. doi:10.1002/jso.20359.
Bani-Hani KE, Bani-Hani BK (мај 2008). „Columnar-lined esophagus: time to drop the eponym of "Barrett": Historical review”. Journal of Gastroenterology and Hepatology. 23 (5): 707—15. PMID18410605. S2CID21531132. doi:10.1111/j.1440-1746.2008.05386.x.CS1 одржавање: Формат датума (веза).
Zagari, R. M.; Fuccio, L.; Wallander, M-A; Johansson, S.; Fiocca, R.; Casanova, S.; Farahmand, B. Y.; Winchester, C. C.; Roda, E.; Bazzoli, F. (2008). „Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: The Loiano-Monghidoro study”. Gut. 57 (10): 1354—1359. PMID18424568. S2CID206947077. doi:10.1136/gut.2007.145177.
Phillips, W. A.; Lord, R. V.; Nancarrow, D. J.; Watson, D. I.; Whiteman, D. C. (2011). „Barrett's esophagus”. Journal of Gastroenterology and Hepatology. 26 (4): 639—648. PMID21166712. S2CID6540402. doi:10.1111/j.1440-1746.2010.06602.x.
Bello, B.; Zoccali, M.; Gullo, R.; Allaix, M. E.; Herbella, F. A.; Gasparaitis, A.; Patti, M. G. (јануар 2013). „Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up?”. J Gastrointest Surg. 17 (1): 14—20. PMID23090280. S2CID12751199. doi:10.1007/s11605-012-2057-5.CS1 одржавање: Формат датума (веза)
Thomas, T.; Abrams, K. R.; De Caestecker, J. S.; Robinson, R. J. (2007). „Meta analysis: Cancer risk in Barrett's oesophagus”. Alimentary Pharmacology & Therapeutics. 26 (11–12): 1465—1477. PMID17900269. S2CID9930761. doi:10.1111/j.1365-2036.2007.03528.x.
Polednak, Anthony P. (2003). „Trends in survival for both histologic types of esophageal cancer in U.S. Surveillance, epidemiology and end results areas”. International Journal of Cancer. 105 (1): 98—100. PMID12672037. S2CID6539230. doi:10.1002/ijc.11029.